SCHEMBL21064299

SCHEMBL21064299

NNC(=O)C1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14756734 1.00
SCHEMBL3824801 0.88 KDM4E (0.62)
SCHEMBL2827677 0.88 KDM4E (0.62)
SCHEMBL14756718 0.88 KDM4E (0.62)
SCHEMBL18394618 0.86 POLB (0.54)
Hydrochloric Acid SCHEMBL29880849 0.86 KDM4E (0.60)
Hydrochloric Acid SCHEMBL15971577 0.86 KDM4E (0.60)
Hydrochloric Acid SCHEMBL29880648 0.86 KDM4E (0.60)
Hydrochloric Acid SCHEMBL15971806 0.86 KDM4E (0.60)
Hydrochloric Acid SCHEMBL28285385 0.84 POLB (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11298363-B2 Triazolobenzazepines as vasopressin V1a receptor antagonists RICHTER GEDEON NYRT. (HU) 2022-04-12 US disclosed
EP-3724192-A1 TRIAZOLOBENZAZEPINES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS Richter Gedeon Nyrt. (HU) 2020-10-21 EP disclosed
WO-2019116324-A1 TRIAZOLOBENZAZEPINES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS RICHTER GEDEON NYRT. (HU) 2019-06-20 WO disclosed
CN-105873930-B Novel bicyclic compounds and their use as antibacterial agents and β -lactamase inhibitors 费多拉制药公司 2019-02-19 CN disclosed
CN-108884068-A 1- cyano-pyrolidin derivative as DUB inhibitor 特殊治疗有限公司 2018-11-23 CN disclosed